Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PhaseDesign Research
United Statespmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
PhaseDesign Research (PDR) is a consultancy specializing in strategic planning and operations for early-stage biotechnology companies. It has supported clients through regulatory agreement or proof-of-concept milestones across diverse therapeutic modalities and indications. PDR has contributed to client fundraising efforts exceeding $100M in dilutive funding and $8.5M in non-dilutive grants since its founding.
- Therapeutic areas
- OphthalmologyImmunologyNeurologyOncology
- Modalities
- Small moleculePeptidesBiologicDevice
- Industry
- Consulting
02
Partnerships
Extensive network of biotechnology experts available for collaboration when needed
Beyond the preview
Go deeper on PhaseDesign Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PhaseDesign Research.